A neurodevelopmental disorder associated with a loss-of-function missense mutation in RAB35
Adriana Aguila,Somaya Salah,Gopinath Kulasekaran,Moatasem Shweiki,Nava Shaul-Lotan,Hagar Mor-Shaked,Muhannad Daana,Tamar Harel,Peter S. McPherson
DOI: https://doi.org/10.1016/j.jbc.2024.107124
IF: 5.485
2024-04-01
Journal of Biological Chemistry
Abstract:Rab35 (Ras-associated binding protein) is a small GTPase that regulates endosomal membrane trafficking and functions in cell polarity, cytokinesis, and growth factor signaling. Altered Rab35 function contributes to progression of glioblastoma, defects in primary cilia formation, and altered cytokinesis. Here, we report a pediatric patient with global developmental delay, hydrocephalus, a Dandy-Walker malformation, axial hypotonia with peripheral hypertonia, visual problems, and conductive hearing impairment. Exome sequencing identified a homozygous missense variant in the GTPase fold of RAB35 (c.80G>A; p.R27H) as the most likely candidate. Functional analysis of the R27H-Rab35 variant protein revealed enhanced interaction with its guanine-nucleotide exchange factor, DENND1A and decreased interaction with a known effector, MICAL1, indicating that the protein is in an inactive conformation. Cellular expression of the variant drives the activation of Arf6, a small GTPase under negative regulatory control of Rab35. Importantly, variant expression leads to delayed cytokinesis and altered length, number, and Arl13b composition of primary cilia, known factors in neurodevelopmental disease. Our findings provide evidence of altered Rab35 function as a causative factor of a neurodevelopmental disorder.
biochemistry & molecular biology